MISSION BIOCAPITAL V LP — Form D/A
MISSION BIOCAPITAL V LP of CAMBRIDGE, MA, a pooled investment fund, filed a Form D amendment with the SEC on 2021-04-13. $191.9M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2021-04-13
- Form: D/A
- Accession: 0001810326-21-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1, 3C.7
- Amount sold: $191.9M
- Date of first sale: 2020-05-07
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-366421
Issuer
- Name: MISSION BIOCAPITAL V LP
- CIK: 0001810326
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 139 MAIN STREET, SUITE 401, CAMBRIDGE, MA, 02142
- Phone: 6172765578
Officers, directors & promoters (1)
| Name | Role | Location |
|---|
| - Mission BioCapital V GP LLC | Promoter | Cambridge, MA |
Other filings by this issuer (1)
More